sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > VEGFR
VEGFR
Cat.No. Product Name Information Area
T4026 VEGFR2 KiN/Ase Inhibitor I VEGFR2 Kinase Inhibitor I is a potent, cell-permeable inhibitor of the VEGFR2 kinase. Others
T3980 Su1498 SU 1498 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2 (VEG... Others
T3571 NSC 247030 NSC 247030 is a biochemical. Others
T3560 Desmethylanethol trithione ADT-OH is a derivative of anethole dithiolethione (ADT) and synthetic hydrogen sulfid... Others
T3463 ACC-789 (NVP-ACC789) ACC-789 (NVP-ACC789; ZK-202650) is an effective, specific and orally active inhibitor... Others
T3476 JI-101 JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth fac... Cardiovascular
T3691 SAR131675 SAR131675 is an effective and specific VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosi... Others
T3599 BFH772 BFH772, a structure analogue of BAW2881, is a potent and selective VEGF inhibitor. BF... Immunology
T3641 BAW2881 BAW2881 is a potent and selective VEGFR inhibitor (vascular endothelial growth factor... Others
T6996 SU5402 SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 ... Others
T6930 Pazopanib HCl (GW786034 HCl) Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEG... Others
T1797 XL184(Cabozantinib malate) Cabozantinib S-malate is the s-malate salt form of cabozantinib, an orally bioavailab... Cancer
T2288 Motesanib Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential... Cancer
T6720 Vatalanib (PTK787) diHydrochloride Vatalanib (PTK787) (IC50=37 nM) is an inhibitor of VEGFR2/KDR. It exhibits less effec... Cancer
T6184 TSU-68 TSU-68,a excellent effective against PDGFR autophosphorylation with Ki of 8 nM, also ... Cancer
T6166 Telatinib Telatinib is an effective inhibitor of VEGFR2/3, c-Kit, and PDGFRα. The IC50s of Tela... Cancer
T6036 Brivanib Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate ... Cancer
T3068 AT9283 AT9283 is an effective multi-targeted inhibitor of JAK2(IC50=1.2 nM) and JAK3(IC50=1... Cancer
T2699 BMS-777607 BMS-777607 is a Met-related inhibitor for c-Met/Axl/Ron/Tyro3 (IC50: 3.9/1.1/1.8/4.3 ... Endocrine system
T2656 Fruquintinib Fruquintinib is an orally available, small molecule inhibitor of vascular endothelial... Cancer
T2642 PD173074 PD173074 is an effective FGFR1 inhibitor (IC50: 25 nM) and also inhibits VEGFR2 (IC50... Cancer
T2620 G-749 G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the ... Cardiovascular System
T2586 Cabozantinib Cabozantinib is an orally bioavailable, small molecule receptor tyrosine kinase (RTK)... Cancer
T2582 Apatinib Apatinib is an orally bioavailable and specific VEGFR2 inhibitor (IC50: 1 nM). In add... Cancer
T2576 Brivanib alaninate Brivanib Alaninate is the alaninate salt of a vascular endothelial growth factor rece... Cancer
T2514 Linifanib Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR ... Cancer
T2500 Cediranib Cediranib (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of... Cancer
T2496 Semaxanib (SU5416) Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor (IC50: 1.23 μ... Cancer
T2456 Tivozanib Tivozanib is an orally bioavailable inhibitor of vascular endothelial growth factor r... Cancer
T2446 KI8751 KI8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM. Cancer
1